For example, in both NKX2-5 and in GATA4 (Table 1), two well-known CHD risk genes, two cases but no controls had a rare predicted deleterious SNV, explaining the weak genotype evidence as reflected in the association P-values (0.119) of the two genes. This evidence concerns the gene GATA4 and coronary artery disorder.